In hepatitis B vaccine debate, CDC panel sidesteps key exposure risk

The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most recent meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup